Mediwelcome Healthcare Management & Technology Inc. (HK:2159)
:2159
Top Page
Mediwelcome Healthcare Management & Technology Inc.
(2159)
Select Model
Select Model
Rating:47Neutral
Price Target:
HK$1.00
▼(-19.35% Downside)
Action:ReiteratedDate:01/31/26
The score is held down primarily by weak financial fundamentals—declining revenue, ongoing losses, and negative operating/free cash flow—along with a negative P/E that limits valuation confidence. Technicals are mixed and provide only modest support, with largely neutral momentum and the price above the 200-day average but below the 20-day average.
Positive Factors
Recurring revenue model
A subscription/licensing-based revenue mix creates recurring income and customer stickiness. Combined with structural digital-health adoption and telehealth tailwinds, this supports predictable revenue streams and long-term customer relationships even as near-term sales fluctuate.
Negative Factors
Declining revenue trend
Sustained top-line decline erodes scale, reduces pricing power, and weakens recurring revenue benefits. Over months, shrinking revenue makes it harder to leverage fixed costs, threatens customer retention economics, and increases reliance on new sales to restore growth momentum.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring revenue model
A subscription/licensing-based revenue mix creates recurring income and customer stickiness. Combined with structural digital-health adoption and telehealth tailwinds, this supports predictable revenue streams and long-term customer relationships even as near-term sales fluctuate.
Read all positive factors
Mediwelcome Healthcare Management & Technology Inc. (2159) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$504.00M
Dividend YieldN/A
Average Volume (3M)143.19K
Price to Earnings (P/E)24.6
Beta (1Y)0.59
Revenue Growth-5.38%
EPS Growth63.93%
CountryHK
Employees311
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.08
Shares Outstanding280,000,000
10 Day Avg. Volume118,880
30 Day Avg. Volume143,186
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.31
Price to Sales (P/S)0.29
P/FCF Ratio-3.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mediwelcome Healthcare Management & Technology Inc. Business Overview & Revenue Model
Company Description
Mediwelcome Healthcare Management & Technology Inc. (2159) is a healthcare technology company that focuses on providing innovative management solutions and advanced technology services for the healthcare sector. The company operates across various...
How the Company Makes Money
Mediwelcome generates revenue primarily through the sale of its healthcare management software and technology services. Key revenue streams include subscription fees from healthcare providers for access to its software solutions, licensing fees fo...
Mediwelcome Healthcare Management & Technology Inc. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 307.94M | 321.56M | 331.31M | 323.37M | 708.36M | 432.29M |
| Gross Profit | 52.10M | 51.00M | 29.89M | 32.55M | 93.60M | 96.31M |
| EBITDA | -14.94M | -33.61M | -74.53M | -69.08M | 11.32M | 46.65M |
| Net Income | -29.16M | -45.24M | -94.10M | -89.20M | 4.64M | 21.04M |
Balance Sheet | ||||||
| Total Assets | 219.14M | 194.09M | 214.32M | 317.83M | 366.70M | 280.08M |
| Cash, Cash Equivalents and Short-Term Investments | 94.24M | 71.66M | 80.35M | 154.02M | 174.83M | 104.89M |
| Total Debt | 49.38M | 47.73M | 31.13M | 26.48M | 25.18M | 25.43M |
| Total Liabilities | 150.73M | 120.81M | 94.35M | 116.97M | 73.21M | 109.08M |
| Stockholders Equity | 64.23M | 71.14M | 116.13M | 195.02M | 283.11M | 161.18M |
Cash Flow | ||||||
| Free Cash Flow | 10.32M | -27.10M | -77.18M | -22.75M | -24.73M | 17.31M |
| Operating Cash Flow | 10.47M | -14.05M | -75.58M | -18.46M | 262.00K | 31.12M |
| Investing Cash Flow | -9.88M | -326.00K | 16.46M | -8.36M | -16.77M | -10.98M |
| Financing Cash Flow | 11.22M | 5.68M | 906.00K | 54.00K | 92.84M | -4.79M |
Mediwelcome Healthcare Management & Technology Inc. Technical Analysis
Neutral
1.24
Price Trends
1.56
Positive
1.38
Positive
1.31
Positive
Market Momentum
0.12
Positive
50.94
Neutral
34.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2159, the sentiment is Neutral. The current price of 1.24 is below the 20-day moving average (MA) of 1.87, below the 50-day MA of 1.56, and below the 200-day MA of 1.31, indicating a neutral trend. The MACD of 0.12 indicates Positive momentum. The RSI at 50.94 is Neutral, neither overbought nor oversold. The STOCH value of 34.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2159.
Mediwelcome Healthcare Management & Technology Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
54 Neutral | HK$126.61M | -18.49 | -18.69% | ― | -4.50% | 75.98% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | HK$604.46M | -20.98 | -10.69% | 1.72% | -3.49% | -1567.01% | |
47 Neutral | HK$504.00M | 24.63 | 11.07% | ― | -5.38% | 63.93% | |
45 Neutral | HK$5.46B | -110.24 | -2.28% | ― | -4.99% | 47.18% | |
44 Neutral | HK$707.18M | -17.95 | -21.11% | ― | ― | ― | |
41 Neutral | HK$1.08B | -176.64 | -13.92% | ― | -32.17% | -1.20% |
* Healthcare Sector Average
HK:2159
Mediwelcome Healthcare Management & Technology Inc.
1.80
1.37
318.60%
HK:2138
EC Healthcare
0.51
-0.09
-15.00%
HK:2158
Yidu Tech, Inc.
5.12
0.15
3.02%
HK:2251
Beijing Airdoc Technology Co. Ltd. Class H
10.91
-0.09
-0.82%
HK:0401
Wanjia Group Holdings Ltd.
0.11
0.06
130.61%
HK:9686
NEUSOFT XIKANG HOLDINGS INC.
0.84
0.14
20.00%
Mediwelcome Healthcare Management & Technology Inc. Corporate Events
Mediwelcome Eyes Full Acquisition of AI-Driven Medical Tech Firm MediAI
Jan 20, 2026
Mediwelcome Healthcare Management Technology Inc. has announced that a subsidiary has signed a non-binding memorandum of understanding to acquire 100% of MediAI Technology Development Limited, whose group provides AI technology solutions to globa...
Mediwelcome Clarifies Auditor Resignation Amid Cost-Cutting Drive
Jan 16, 2026
Mediwelcome Healthcare Management Technology Inc. has issued a supplemental announcement clarifying the circumstances around the resignation of its auditor, Moore CPA Limited, following an earlier decision to change auditors due to audit fees dee...
Mediwelcome Healthcare Announces Auditor Change Amid Cost Control Measures
Nov 28, 2025
Mediwelcome Healthcare Management Technology Inc. announced a change in its auditor, with Moore CPA Limited resigning due to disagreements over audit fees. The company has appointed Rongcheng (Hong Kong) CPA Limited as the new auditor to maintain...
Mediwelcome Announces New Hong Kong Business Location
Nov 18, 2025
Mediwelcome Healthcare Management Technology Inc. has announced a change in its principal place of business in Hong Kong to a new location at World-Wide House, effective from November 18, 2025. This move is part of the company’s strategic o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.